GENE ONLINE|News &
Opinion
Blog

Karuna Therapeutics
JPMJP Morgan 2024
JPM 2024: Biotech Companies Mapping Out Their Future, and a New Round of M&A Spree Begins
2024-01-09
AstraZenecaAsthma
AstraZeneca’s severe asthma drug Tezspire has been granted market authorization in South Korea
2023-12-25
m&aBristol Myers SquibbKaruna TherapeuticsNeuroscience
Bristol Myers Squibb Acquires Karuna Therapeutics to Enhance Neuroscience Portfolio
2023-12-25
Anxiety
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Neuroscience
Zai Lab Buys Rights to Three Assets, Including Its First Neuroscience Drug
2021-11-10
LATEST
Health Insurers Adopt Wearable Data Tracking Models Similar to Automotive Telematics
2026-08-14
Biogen’s Alzheimer’s Tau Drug Splits Experts: Can Diranersen Challenge Leqembi?
2026-08-14
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
La Mojana Earthworks Reveal Long-Term Sustainable Water Management by Pre-Hispanic Societies
2026-08-13
Grant Evaluators Divided Over Prioritizing Past Performance Versus Future Potential
2026-08-13
UC Riverside Study Finds High-Intensity Running Does Not Reduce Lifespan in Mice
2026-08-13
READ MORE
EVENT
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
2026-10-23
ESMO Congress 2026 (Oncology Breakthroughs)
Madrid, Spain
SEE MORE
Scroll to Top